Soleno Therapeutics Inc. (SLNO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Soleno Therapeutics Inc.

NASDAQ: SLNO · Real-Time Price · USD
64.96
2.24 (3.57%)
At close: Sep 26, 2025, 3:59 PM
64.76
-0.31%
After-hours: Sep 26, 2025, 04:54 PM EDT

Soleno Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
87.93M 169.68M 14.6M 21.3M
Short-Term Investments
203.51M n/a n/a n/a
Long-Term Investments
27.21M n/a n/a n/a
Other Long-Term Assets
83K 165K n/a 40K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.45M 1.68M 1.04M 1.12M
Total Current Assets
293.89M 171.36M 15.65M 22.42M
Property-Plant & Equipment
2.98M 419K 157K 454K
Goodwill & Intangibles
6.8M 8.75M 10.69M 12.64M
Total Long-Term Assets
37.08M 9.33M 10.85M 13.13M
Total Assets
330.97M 180.69M 26.5M 35.55M
Account Payables
8.88M 3.15M 1.78M 3.25M
Deferred Revenue
n/a n/a n/a 4.15M
Short-Term Debt
526K n/a 155K 282K
Other Current Liabilities
9.34M 4.95M 3.55M 769K
Total Current Liabilities
18.75M 11.51M 7.31M 8.01M
Long-Term Debt
49.83M n/a n/a n/a
Other Long-Term Liabilities
14.81M 11.55M 8.84M 9.58M
Total Long-Term Liabilities
67.11M 11.68M 8.84M 9.75M
Total Liabilities
85.86M 23.18M 16.15M 17.76M
Total Debt
52.83M 403K 155K 457K
Book Value
245.11M 157.51M 10.35M 17.79M
Book Value Per Share
6.10 9.55 1.23 3.35
Common Stock
46K 32K 8K 80K
Retained Earnings
-452.26M -276.41M -237.42M -213.35M
Comprehensive Income
n/a 0.00 n/a -0.00
Shareholders Equity
245.11M 157.51M 10.35M 17.79M
Total Investments
230.72M n/a n/a n/a